Explore our brands

Our brands bring together the industry's most influential leaders and scientific experts, inspiring thought-provoking and insightful content that offers a unique perspective on R&D trends and challenges.
Contact

Resources

The latest in from biologics discovery and development through to production and supply chain management.

Top R&D Stories of 2023

Through captivating articles, insight pieces, and spotlight interviews, we delve into the remarkable innovations, breakthroughs, and scientific marvels that have defined the landscape of research over the past year.
Read Now
Oligonucleotides

Japanese Team Successfully Skip Abnormal Gene In Vitro With Antisense Oligonucleotide for BPAN

Rare disease BPAN currently has no treatment options, this new research investigates whether antisense oligonucleotide therapies could be the answer to address this unmet need.
Read More
Oligonucleotides

Oligo Sequencing Technologies - What Methods and Techniques Are Utilized in the Pharmaceutical Industry?

Oligo sequencing revolutionizes biologics research, ensuring accurate analysis of oligonucleotides. Biologics by Oxford Global explores methods, safety, sustainability, and future trends. Despite challenges, advancements promise exciting opportunities for scientific discovery.
Read More
Oligonucleotides

Innovation at the Crossroads: Oligonucleotide Therapeutics and the Evolution of Drug Design

Can oligonucleotide therapeutics shape the future of healthcare? We journey through AI frontiers, sustainable synthesis, and regulatory challenges.
Read More
Oligonucleotides

Sustainability in Pharmaceutical Manufacture and Healthcare Provision

How do things stand with sustainability in pharmaceutical manufacture at present? What are some members of the industry doing to reduce their carbon footprint?
Read More
Oligonucleotides

New Approach to Oligo-Peptide Synthesis from Novo and Aarhus University

The collaboration could unlock the more cost-effective synthesis of oligonucleotide-peptide conjugates.
Read More
Oligonucleotides

How Do Regulatory Considerations Impact the Clinical Development of Oligonucleotide Therapies?

What are the regulatory considerations that need to be made in the clinic for oligonucleotide therapies? What's the existing guidance for this emerging modality?
Read More
Oligonucleotides

Revolutionizing Biologics: Unveiling the Challenges and Innovations in Large-Scale Oligonucleotide Synthesis 

Read More
Oligonucleotides

Assessment of Long IVT mRNA Fragments with the Aligent Fragment Analyzer Systems

Read More
Oligonucleotides

Early Formulation Screening with Merck

Read More
Oligonucleotides

Early-Stage Development of LNP Formulations

Read More
Oligonucleotides

Friedrich Miescher: The Pioneer of Nucleic Acid Discovery

As medical research that is founded on nucleic acids continues to progress, we take a step back to look at the man who first discovered nucleic acids.
Read More
Oligonucleotides

GMP Manufacturing of LNP Formulations

Read More

Subscribe to Our Newsletter

Sign up for our monthly newsletter to
keep up with all things biologics